Jamshed Bomanji
Jamshed Bomanji is a full professor, clinical lead, and head of the Institute of Nuclear medicine department at the University College Hospital (UCLH) NHS foundation trust based in London, UK.[1]
Education and career
Professor Bomanji obtained a
Jamshed Bomanji also serves as the editor-in-chief at the Nuclear Medicine Communications.[2] His comments on cancer procedures using nuclear medicine techniques are documented by Hospitals[3] and private companies.[4][5][6]
Books
Jamshed has authored 20 book Chapters. He is Editor Hybrid Imaging series, 14 books.
Publications
He has published more than 295 scientific Manuscripts, with over 6000 Citations.[12] His manuscript titled "Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐D Phe1,Tyr3‐octreotate) and 18F‐FDG" published in 2008 has been cited more than 300 times alone. He published his first research paper in 1984 titled "123 I meta-iodo-benzyl guanidine: Synthesis and imaging the adrenal medulla and phaeochromocytoma" in the Journal of Nuclear Medicine in Research and Practice. Launched new suite of educational PET/CT webinars for the British Institute of Radiology 2019.
References
- ^ a b "UCLH website". Archived from the original on 5 June 2020.
- ^ "LWW website".
- ^ "UCLH News".
- ^ "Prnewswire website" (Press release).
- ^ "Biospace website".
- ^ "Eurekalert website".
- OCLC 906032566.
- OCLC 17924070.
- )
- OCLC 1091713200.
- )
- ^ "Scopus website".